Healthcare Industry News: PENTAX Medical
News Release - December 4, 2013
SMART Medical Systems Announces Strategic Alliance with PENTAX Medical in the EMEA Countries, Aimed to Improve Patient Care in Colonoscopy
RA'ANANA, Israel, December 4, 2013 -- (Healthcare Sales & Marketing Network) --SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa (EMEA)."Partnering with PENTAX Medical is an ultimate way for us to bring the G-EYE™ colonoscopy solution to the market," said Gadi Terliuc, Founder and CEO of SMART. "Our mission is to provide the GI specialists with the most advanced endoscopy device so that they can provide the best possible care to their patients. PENTAX Medical, as a market leader in the endoscopy field, can make the G-EYE™ a widely available product and a new standard of care in colonoscopy."
The G-EYE™ endoscope was formally launched at the recent United European Gastroenterology Week (UEGW), held in Berlin, Germany. The commercial G-EYE™ model, based on the PENTAX i10 Full HD+ colonoscope, was demonstrated in the PENTAX Medical booth at the UEGW exhibition. The results of a clinical study comparing G-EYE™ colonoscopy detection yield to conventional colonoscopy, reporting substantial increase in polyp and adenoma detection and significantly reduced miss-rate, were presented at the UEGW scientific conference.
About SMART Medical Systems
SMART Medical Systems is a pioneer in the development and manufacture of innovative medical devices in the field of gastro-intestinal (GI) endoscopy. Its proprietary technology enhances the performance and capabilities of existing endoscopy equipment, in an intuitive and cost-effective manner. SMART's CE Marked and FDA cleared NaviAid™ product family is commercially distributed in key global markets. Its G-EYE™ product (CE Marked, pending FDA clearance) is presently under commercialization in selected regions. SMART is headquartered in Israel, and operates in the United States through its wholly-owned subsidiary, SMART GI Inc., and in Greater China through its Hong Kong subsidiary, Medico HK Limited. For more information, please visit: http://www.smartmedsys.com
Source: Smart Medical Systems
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
